Academic Journal

Serum Cholesterol Efflux Capacity in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

التفاصيل البيبلوغرافية
العنوان: Serum Cholesterol Efflux Capacity in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
المؤلفون: Yasuo Yanagi, MD, PhD, Richard M.C. Yu, PhD, Waseem Ahamed, MS, Marco Yu, PhD, Kelvin Yi Chong Teo, MBBS, MMed (Ophth), Anna C.S. Tan, MBBS, Ching-Yu Cheng, MD, PhD, Tien Yin Wong, MD, PhD, Rajendra S. Apte, MD, PhD, Chui Ming Gemmy Cheung, FRCOphth
المصدر: Ophthalmology Science, Vol 2, Iss 2, Pp 100142- (2022)
بيانات النشر: Elsevier, 2022.
سنة النشر: 2022
المجموعة: LCC:Ophthalmology
مصطلحات موضوعية: Age-related macular degeneration, Cholesterol efflux, Drusen, Lipoprotein, Polypoidal choroidal vasculopathy, Ophthalmology, RE1-994
الوصف: Purpose: To investigate serum cholesterol efflux capacity (the ability of the serum to accept cholesterol) and factors that regulate it using nuclear magnetic resonance-quantified measures of lipoprotein particle composition and size and apolipoproteins metrics in patients with age-related macular degeneration (AMD). Design: Case-control study. Participants: Four hundred two serum samples from 80 patients with early AMD (eAMD), and 212 patients with neovascular AMD (nAMD), including 80 with typical nAMD (tAMD) and 132 with polypoidal choroidal vasculopathy (PCV), and 110 age- and gender matched control participants. Methods: Serum from participants showed cholesterol efflux capacity measured using in vitro cell assays and lipoprotein subfractions measured using nuclear magnetic resonance (Nightingale, Ltd). Associations between cholesterol efflux capacity (measured in percentage) and lipid subfractions were investigated in the patients and control participants. Main Outcome Measures: Cholesterol efflux capacity and lipid subfractions in control, eAMD, and nAMD. Associations between HDL subfractions and cholesterol efflux capacity. Results: Cholesterol efflux capacity was higher in patients with eAMD (68.0 ± 11.3% [mean ± standard deviation]) and nAMD (75.9 ± 27.7%) than in the control participants (56.9 ± 16.7%) after adjusting for age, gender, and use of lipid-lowering drug (P < 0.0001). Nuclear magnetic resonance lipidomics demonstrated that the mean diameter of HDL was larger both in eAMD (9.96 ± 0.27 mm [mean ± standard deviation]) and PCV (9.97 ± 0.23 mm) compared with that of the control participants (9.84 ± 0.24 mm; P = 0.0001 for both). Among the 28 HDL subfractions, most of the small, medium, and large HDLs, but none of the 7 extra large HDLs fractions, were associated moderately with cholesterol efflux capacity in eAMD and PCV (R = 0.149–0.277). Conclusions: Serum cholesterol efflux capacity was increased in eAMD and PCV, but not tAMD, possibly reflecting differential underlying pathophysiologic features of lipid dysregulation in tAMD and PCV. Further studies should be directed toward investigating the diverse biological activities of HDL in AMD, including macular pigment transport, regulation of inflammation, and local cholesterol transport system.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2666-9145
Relation: http://www.sciencedirect.com/science/article/pii/S2666914522000318; https://doaj.org/toc/2666-9145
DOI: 10.1016/j.xops.2022.100142
URL الوصول: https://doaj.org/article/573ef46f93b44e8f92f24288b3c950ce
رقم الانضمام: edsdoj.573ef46f93b44e8f92f24288b3c950ce
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:26669145
DOI:10.1016/j.xops.2022.100142